NGM Biopharmaceuticals (NGM) Financials

$1.54

$0.00 (0.00%)

As on 08-Apr-2024 09:30EDT

Market cap

$129 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	4.42	55.33	77.88	87.37	103.54	108.67
Cost of Revenue	2.22	5.98	7.90	163.97	62.26	39.32
Gross Profit	2.20	55.33	77.88	87.37	103.54	108.67
Operating Expenses	148.74	221.58	198.58	191.20	152.88	112.98
Operating Profit (EBIT)	-146.55	-166.25	-120.70	-103.83	-49.34	-4.31
Other Income	--	--	-0.06	-0.59	-0.15	--
Profit before Tax	-142.38	-162.67	-120.34	-102.49	-42.80	-0.49
Provision for Tax	--	-3.58	-6.51	-8.49	-14.30	3.82
Profit after Tax (Net Income)	-142.38	-159.09	-113.83	-93.99	-28.50	-0.49
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-162.67	-120.34	-102.49	-42.80	-0.49

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	148.64	259.56	335.65	280.04	330.72	186.88
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.15	14.20	5.39	6.42	9.97	17.72
Current Liabilities	20.08	47.84	61.36	42.58	39.72	41.49
Total Liabilities	168.87	307.40	402.39	329.04	380.40	246.09

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	12.42	18.54	23.11	20.62	25.16	31.53
Current Assets	156.44	288.86	379.28	308.43	355.25	214.56
Total Assets	168.87	307.40	402.39	329.04	380.40	246.09
Total Debt*	--	5.39	10.46	--	--	--
Net Current Assets	136.36	241.02	317.93	265.84	315.53	173.07

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-132.20	-144.44	-73.23	-83.50	-41.17	-7.60
Cash Flow from Investing Activities	--	14.32	-71.65	-51.00	48.72	38.73
Cash from Financing Activities	1.78	54.23	149.66	35.54	180.75	0.20
Net Cash Inflow / Outflow	--	--	4.78	-98.96	188.30	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.74	-1.99	-1.48	-1.38	-0.57	-0.08
Cash EPS ($)	-1.71	-1.94	-1.40	-1.29	-0.42	1.12
Adjusted Book Value ($)	1.81	3.24	4.36	4.12	6.61	31.15
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.61	-1.81	-0.95	-1.23	-0.82	-1.27
Free Cash Flow per Share ($)	-1.63	-1.83	-0.97	-1.26	-0.89	-2.24

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-68.85	-52.07	-36.36	-30.78	-11.01	-1.50
ROE (%)	-69.76	-53.46	-36.98	-30.78	-11.01	-1.50
ROA (%)	-59.79	-44.83	-31.12	-26.50	-9.10	-0.20
EBIT Margin (%)	-3,317.79	-300.45	-154.97	-118.85	-47.65	-3.97
Net Margin (%)	-3,223.34	-287.50	-146.26	-108.32	-27.56	-0.45
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-0.92	-0.29	-0.11	-0.16	-0.05	0.41
EBIT Growth (%)	11.85	-37.74	-16.24	-110.44	-1,043.72	75.24
Net Profit Growth (%)	10.50	-39.76	-21.10	-229.82	-5,680.53	96.52
EPS Growth (%)	0.13	-0.35	-0.07	-1.43	-5.94	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-0.49	-2.52	-11.98	-21.92	-32.44	--
Price / Book Value	0.47	1.55	4.06	7.36	2.80	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.53	-0.84	-8.79	-18.14	-13.90	--
Close Price ($)	0.86	5.02	17.71	30.30	18.49	--
High Price ($)	5.68	19.14	32.12	32.05	20.50	--
Low Price ($)	0.60	2.92	14.90	9.25	8.81	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.02	0.03	--	--	--
Short term debt to equity ratio	--	0.02	0.02	--	--	--
Current Ratio	7.79	6.04	6.18	7.24	8.94	5.17
Quick Ratio	--	6.04	6.18	7.24	8.94	--
Interest Coverage	--	-44.76	-18.72	-53.55	--	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	1.31	13.70	6.35	7.36	5.03	3.38
Asset Turnover	0.02	0.16	0.21	0.25	0.33	0.44
Receivable days	315.80	41.34	26.68	24.33	15.65	12.33
Inventory Days	0.00	0.00	0.00	0.00	0.00	--
Payable days	940.26	418.08	344.70	20.82	43.42	35.61
Cash Conversion Cycle	-624.46	-376.74	-318.02	3.51	-27.76	--